Home
Knowledge Center

Knowledge Center

The latest insights, news, events and webinars from Phastar

The Cutting Edge of Biometrics

Keep up-to-date with the latest trends and developments with insights from our biostatisticians, programmers, and data scientists.

Press Releases

Phastar Scoops Multiple Finalist Positions in 2025 Scrip Awards

October 1st, 2025 3 minute read

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as fi...

Press Releases

Phastar Appoints Industry Veteran Billy Amzal as Head of Strategic Consulting

June 24th, 2025 2 minute read

London, UK, and Durham (NC), US – June 24th, 2025: Phastar, a global specialist biometrics & data science Contrac...

Press Releases

Phastar Secures Finalist Spot at 2025 Citeline Awards

April 10th, 2025 3 minute read

London, UK, and Durham (NC), US – April 10th, 2025: Phastar, a global specialist biometrics & data science Contra...

View all

Events

Meet Phastar at PHUSE US Connect 2026

November 17th, 2025 1 minute read

Phastar is delighted to be exhibiting at PHUSE US Connect in Austin Texas, from 22nd – 26th March 2026.

Events

Meet Phastar at PHUSE APAC Connect 2026

November 17th, 2025 1 minute read

Phastar is delighted to be exhibiting at PHUSE APAC Connect in Hyderabad, India from 19th – 21st February 2026.

Events

Meet Phastar at PSI 2026

November 17th, 2025 1 minute read

Phastar is delighted to be exhibiting at PSI in Belfast from 15th – 17th June 2026. Visit the Phastar team at B...

View all

Webinars

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls

November 20th, 2025 1 minute read

Use of external data to augment clinical trials has been increasingly evaluated and is transforming drug development ...

Webinars

SDTM Workflow Transformation: Faster, Easier and More Reliable

November 14th, 2025 1 minute read

The demand for rapid, cost-effective, and standards-compliant SDTM delivery continues to increase across the biotech ...

Webinars

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

October 30th, 2025 1 minute read

The early stages of clinical development are critical, decisions made here can determine the efficiency, cost, and ul...

View all

Case Studies

Turning Legacy Complexity into Submission-Ready Confidence

November 24th, 2025 1 minute read

Discover how Phastar converted 16 legacy studies into SDTM and delivered a robust Integrated Summary of Safety (ISS) ...

Case Studies

Delivering a Complex Integrated Summary of Effectiveness: Efficient Pooling and Advanced Analysis Across Four Multiple Sclerosis Spasticity Studies

November 17th, 2025 1 minute read

A sponsor needed to pool data from four MS spasticity studies—one still ongoing with another vendor—while adapting mi...

Case Studies

IDAC for a Phase III Study in Thrombotic Microangiopathy: Delivering High-Quality Statistical Support Within Budget Constraints

November 12th, 2025 1 minute read

Phastar acted as the Independent Data Analysis Centre (IDAC) for a Phase III trial in thrombotic microangiopathy (TMA...

View all

Articles & Interviews

Exploring the Use of Patient Reported Outcomes for Primary Endpoints

December 23rd, 2025 1 minute read

As patient-centerd research continues to shape clinical trial design, electronic patient-reported outcomes (ePROs) ar...

Articles & Interviews

Statistical Considerations in Decentralized Clinical Trials

December 10th, 2025 1 minute read

Decentralized clinical trials (DCTs) continue to gain momentum as sponsors look to reduce participant burden, improve...

Articles & Interviews

Hybrid DCTs Set for Surge as Innovation Outpaces Regulatory Hurdles

December 8th, 2025 2 minute read

As APAC continues to embrace digital innovation, hybrid decentralized clinical trials (DCTs) are emerging as a practi...

View all

Blogs

Designing Early-Phase Clinical Trials: Where to Begin and What to Consider

December 16th, 2025 4 minute read

Designing an early-phase clinical trial is one of the most important, and most complex, steps in drug development. Th...

Blogs

Meet the Team: Alice Wang, Associate Director of Data Science

December 5th, 2025 4 minute read

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each te...

Blogs

Early Phase Clinical Trials: An Ever-Changing Landscape

December 2nd, 2025 5 minute read

The early stages of clinical development are critical, and the decisions made here determine not only the efficiency ...

View all

Publications

Leveraging Real-World Data for in-silico Trials: Enhancing Clinical Development and Regulatory Confidence

December 3rd, 2025 1 minute read

As the pharmaceutical landscape evolves, traditional clinical trial designs are increasingly complemented by innovati...

Publications

Advancing Clinical Trial Design with Bayesian Statistics and Prior Elicitation

April 1st, 2025 1 minute read

Discover how Bayesian statistics can enhance clinical trial efficiency and improve decision-making. Our latest white ...

Publications

Unlock the Power of Real-World Evidence in Clinical Research

February 25th, 2025 1 minute read

Discover how Real-World Evidence (RWE) is revolutionizing drug development and clinical decision-making in our latest...

View all

Knowledge Center

The Cutting Edge of Biometrics

Press Releases

Phastar Scoops Multiple Finalist Positions in 2025 Scrip Awards

Phastar Appoints Industry Veteran Billy Amzal as Head of Strategic Consulting

Phastar Secures Finalist Spot at 2025 Citeline Awards

Events

Meet Phastar at PHUSE US Connect 2026

Meet Phastar at PHUSE APAC Connect 2026

Meet Phastar at PSI 2026

Webinars

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls

SDTM Workflow Transformation: Faster, Easier and More Reliable

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

Case Studies

Turning Legacy Complexity into Submission-Ready Confidence

Delivering a Complex Integrated Summary of Effectiveness: Efficient Pooling and Advanced Analysis Across Four Multiple Sclerosis Spasticity Studies

IDAC for a Phase III Study in Thrombotic Microangiopathy: Delivering High-Quality Statistical Support Within Budget Constraints

Articles & Interviews

Exploring the Use of Patient Reported Outcomes for Primary Endpoints

Statistical Considerations in Decentralized Clinical Trials

Hybrid DCTs Set for Surge as Innovation Outpaces Regulatory Hurdles

Blogs

Designing Early-Phase Clinical Trials: Where to Begin and What to Consider

Meet the Team: Alice Wang, Associate Director of Data Science

Early Phase Clinical Trials: An Ever-Changing Landscape

Publications

Leveraging Real-World Data for in-silico Trials: Enhancing Clinical Development and Regulatory Confidence

Advancing Clinical Trial Design with Bayesian Statistics and Prior Elicitation

Unlock the Power of Real-World Evidence in Clinical Research

Speak to our Team of Experts